Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantomic is an Australian biotechnology company specializing in the development of quantum-enhanced diagnostic platforms. The company leverages Quantum Diamond Sensing (QDS) technology to achieve ultra-high sensitivity in protein biomarker detection, surpassing the limits of traditional ELISA and other conventional assays. By detecting low-abundance proteins in blood and other biofluids, Quantomic's platform facilitates the early diagnosis of complex conditions such as cancer and neurodegenerative disorders. Their technology is designed to be integrated into clinical workflows, providing a scalable solution for precision medicine and drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantomic.